The relationship between follicle-stimulating hormone and metabolic dysfunction-associated fatty liver disease in men
Open Access
- 11 July 2024
- journal article
- research article
- Published by Springer Nature in Nutrition & Diabetes
- Vol. 14 (1) , 1-8
Abstract
Objectives: The present study aimed to investigate the relationship between male hormones and metabolic dysfunction-associated fatty liver disease (MAFLD) in males. Methods: Data from the Fangchenggang Area Male Health and Examination Survey (FAMHES) were used to analyze the male hormone levels between MAFLD patients and controls. Univariate and multivariate logistic regression analyses were performed to identify risk factors for MAFLD. Receiver operating characteristic curve analysis was used to assess the diagnostic performance of male hormones for MAFLD. Result: A total of 1578 individuals were included, with 482 individuals (30.54%) of MAFLD, including 293 (18.57%) with mild disease and 189 (11.98%) with moderate-to-severe disease. The MAFLD patients were significantly older than those without MAFLD. The LH, FSH, and SHBG levels in the MAFLD patients were significantly greater than those in the control group. Age, FSH, LH, SHBG, and estradiol were all risk factors for MAFLD. Age, FSH, and LH were risk factors for moderate-to-severe MAFLD. FSH was an independent risk factor for MAFLD and moderate-to-severe MAFLD. FSH showed an excellent diagnostic value, with an AUC of 0.992 alone and 0.996 after adjusting age. Conclusions: Our findings indicate that FSH may be a potential diagnostic and predictive biomarker for MAFLD.Keywords
This publication has 50 references indexed in Scilit:
- MAFLD: an optimal framework for understanding liver cancer phenotypesJournal of Gastroenterology, 2023
- A cross-sectional analysis of the association between testosterone and biopsy-proven non-alcoholic fatty liver disease in men with obesityEndocrine, 2023
- Association of non-alcoholic fatty liver disease with total testosterone in non-overweight/obese men with type 2 diabetes mellitusJournal of Endocrinological Investigation, 2023
- Androgens and spermatogenesisAnnales d'Endocrinologie, 2022
- Metabolic syndrome and male fertility disorders: Is there a causal link?Reviews in Endocrine and Metabolic Disorders, 2021
- Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver DiseaseArchives of Medical Research, 2021
- Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta‐AnalysisHepatology, 2019
- Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research GapsHepatology, 2019
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015
- The central role of Sertoli cells in spermatogenesisSeminars in Cell & Developmental Biology, 1998